We are live on ! Find out more
WP

WMS Partners Portfolio holdings

AUM $1.78B
1-Year Est. Return 11.82%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+11.82%
3 Year Est. Return
+10.77%
5 Year Est. Return
+74.56%
10 Year Est. Return
+198.1%
AUM
$721M
AUM Growth
+$1.14M
Cap. Flow
-$12.6M
Cap. Flow %
-1.75%
Top 10 Hldgs %
39.86%
Holding
228
New
32
Increased
59
Reduced
55
Closed
26

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.52%
2 Technology 15.18%
3 Industrials 13.85%
4 Healthcare 12.93%
5 Financials 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
201
DELISTED
Allergan plc
AGN
$202K 0.03%
873
-1,296
-60% -$299K
DUK icon
202
Duke Energy
DUK
$93.7B
$201K 0.03%
+2,345
New +$187K
AA icon
203
Alcoa
AA
$13.2B
-12,224
Closed -$281K
AVGO icon
204
Broadcom
AVGO
$1.7T
-40,260
Closed -$622K
BRK.A icon
205
Berkshire Hathaway Class A
BRK.A
$1.08T
-3
Closed -$640K
C icon
206
Citigroup
C
$231B
-16,758
Closed -$700K
F icon
207
Ford
F
$58.3B
-20,890
Closed -$282K
GNW icon
208
Genworth Financial
GNW
$3.91B
-13,475
Closed -$37K
GS icon
209
Goldman Sachs
GS
$302B
-1,854
Closed -$291K
HSIC icon
210
Henry Schein
HSIC
$10B
-4,628
Closed -$313K
IDXX icon
211
Idexx Laboratories
IDXX
$42.2B
-2,569
Closed -$201K
IWV icon
212
iShares Russell 3000 ETF
IWV
$20.3B
-8,157
Closed -$986K
LXRX icon
213
Lexicon Pharmaceuticals
LXRX
$997M
-10,000
Closed -$120K
MANH icon
214
Manhattan Associates
MANH
$12.5B
-3,944
Closed -$224K
MS icon
215
Morgan Stanley
MS
$342B
-17,785
Closed -$445K
NKE icon
216
Nike
NKE
$57B
-3,946
Closed -$243K
PFE icon
217
PUT
Pfizer
PFE
$162B
-26,350
Closed -$741K
SPY icon
218
State Street SPDR S&P 500 ETF Trust
SPY
$815B
-2,152
Closed -$442K
TEL icon
219
TE Connectivity
TEL
$60.4B
-4,220
Closed -$261K
TGT icon
220
Target
TGT
$74.7B
-9,131
Closed -$751K
TRN icon
221
Trinity Industries
TRN
$2.26B
-163,658
Closed -$2.16M
UPLD icon
222
Upland Software
UPLD
$10.9M
-1,740
Closed -$120K
ERF
223
DELISTED
Enerplus Corporation
ERF
-12,000
Closed -$47K
NYMX
224
DELISTED
Nymox Pharmaceutical Corp
NYMX
-21,555
Closed -$53K
MACK
225
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-3,254
Closed -$214K

Similar funds

WMS Partners's Q2 2016 Portfolio in Review

As of Q2 2016, WMS Partners held 228 positions worth $721M, up 0.16% from $719M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

WMS Partners's Q2 2016 filing shows 32 new, 59 increased, 55 reduced and 26 closed positions. Its largest new stake was Ansys: 6,170 shares worth $560K. The largest sale was T. Rowe Price, an estimated $7.12M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • WMS Partners's largest Q2 2016 buy was Ansys: 6,170 shares worth $560K.
  • WMS Partners added most to Vanguard Morningstar Total Stock Market ETF in Q2 2016, an estimated $3.21M increase.
  • WMS Partners's biggest Q2 2016 reduction was T. Rowe Price, cutting an estimated $7.12M.
  • WMS Partners fully exited ADT Corp in Q2 2016, selling an estimated $4.55M.
  • WMS Partners's ten largest holdings make up 40% of its $721M portfolio in Q2 2016.
  • WMS Partners opened 32 new positions and closed 26 in Q2 2016.
  • WMS Partners's portfolio value rose 0.16% quarter-over-quarter to $721M.

Based on WMS Partners's 13F filing for Q2 2016, filed 10 Aug 2016.